Ashok Leyland Ltd
NSE:ASHOKLEY
Ashok Leyland Ltd
NSE:ASHOKLEY
Price:
219.88
INR
Market Closed
Market Cap:
645.7B
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
ASHOKLEY Alert
Ashok Leyland Ltd
219.88
0.00 (0%)
| 52 Week Range |
159.8
262.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Ashok Leyland Ltd
Balance Sheet
Balance Sheet Decomposition
Ashok Leyland Ltd
Ashok Leyland Ltd
| Current Assets | 265.1B |
| Cash & Short-Term Investments | 59.8B |
| Receivables | 147.7B |
| Other Current Assets | 57.5B |
| Non-Current Assets | 440.9B |
| Long-Term Investments | 24.4B |
| PP&E | 62.2B |
| Intangibles | 25.8B |
| Other Non-Current Assets | 328.4B |
| Current Liabilities | 231.5B |
| Accounts Payable | 59.8B |
| Other Current Liabilities | 171.7B |
| Non-Current Liabilities | 371.4B |
| Long-Term Debt | 317.8B |
| Other Non-Current Liabilities | 53.6B |
Balance Sheet
Ashok Leyland Ltd
Ashok Leyland Ltd
Currency: INR
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
78
|
1 064
|
8 400
|
16 812
|
10 131
|
12 181
|
17 674
|
21 883
|
14 810
|
20 310
|
|
| Cash |
78
|
969
|
5 941
|
9 416
|
9 854
|
5 885
|
14 647
|
10 125
|
0
|
0
|
|
| Cash Equivalents |
0
|
95
|
2 459
|
7 396
|
277
|
6 296
|
3 027
|
11 758
|
14 810
|
20 310
|
|
| Short-Term Investments |
0
|
4 744
|
3 246
|
2 935
|
11 324
|
34 157
|
6 328
|
1 832
|
12 754
|
23 533
|
|
| Total Receivables |
20 976
|
32 799
|
43 060
|
48 096
|
58 441
|
73 610
|
108 311
|
100 042
|
96 163
|
111 824
|
|
| Accounts Receivables |
14 194
|
13 944
|
14 147
|
14 784
|
12 601
|
11 987
|
27 299
|
15 069
|
30 406
|
33 006
|
|
| Other Receivables |
6 782
|
18 855
|
28 913
|
33 312
|
45 840
|
61 623
|
81 012
|
84 973
|
65 757
|
78 818
|
|
| Inventory |
20 127
|
17 210
|
15 145
|
19 223
|
29 010
|
22 077
|
30 634
|
15 804
|
25 956
|
26 977
|
|
| Other Current Assets |
1 784
|
4 075
|
1 884
|
1 623
|
2 724
|
2 191
|
1 928
|
13 534
|
9 505
|
2 863
|
|
| Total Current Assets |
42 965
|
59 892
|
71 734
|
88 689
|
111 630
|
144 216
|
164 875
|
153 095
|
159 189
|
185 506
|
|
| PP&E Net |
54 811
|
65 325
|
49 504
|
47 590
|
52 682
|
53 206
|
53 655
|
62 778
|
62 807
|
58 838
|
|
| PP&E Gross |
54 811
|
65 325
|
0
|
47 590
|
52 682
|
53 206
|
53 655
|
62 778
|
62 807
|
58 838
|
|
| Accumulated Depreciation |
24 335
|
29 960
|
0
|
4 393
|
8 058
|
12 822
|
18 334
|
25 758
|
32 104
|
37 321
|
|
| Intangible Assets |
4 898
|
5 550
|
5 082
|
4 642
|
4 591
|
6 072
|
8 920
|
12 115
|
12 983
|
12 189
|
|
| Goodwill |
0
|
7 817
|
10 581
|
7 539
|
11 077
|
11 077
|
11 156
|
11 156
|
12 408
|
10 318
|
|
| Note Receivable |
4 797
|
27 138
|
34 445
|
59 141
|
71 205
|
103 644
|
137 915
|
130 204
|
161 843
|
155 574
|
|
| Long-Term Investments |
23 376
|
6 902
|
13 184
|
7 671
|
8 453
|
9 670
|
8 760
|
7 771
|
8 511
|
9 985
|
|
| Other Long-Term Assets |
120
|
2 718
|
7 217
|
6 714
|
7 046
|
7 295
|
5 939
|
4 150
|
2 929
|
3 597
|
|
| Other Assets |
0
|
7 817
|
10 581
|
7 539
|
11 077
|
11 077
|
11 156
|
11 156
|
12 408
|
10 318
|
|
| Total Assets |
130 967
N/A
|
175 343
+34%
|
191 746
+9%
|
221 987
+16%
|
266 683
+20%
|
335 180
+26%
|
391 219
+17%
|
381 269
-3%
|
420 669
+10%
|
436 008
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
26 544
|
25 924
|
29 598
|
27 011
|
34 501
|
50 746
|
51 790
|
28 346
|
53 462
|
72 499
|
|
| Accrued Liabilities |
1 180
|
1 005
|
1 638
|
2 088
|
9 578
|
9 055
|
4 622
|
3 595
|
1 362
|
2 193
|
|
| Short-Term Debt |
7 670
|
12 645
|
10 443
|
10 727
|
10 347
|
19 192
|
21 378
|
28 427
|
3 382
|
17 837
|
|
| Current Portion of Long-Term Debt |
8 506
|
17 443
|
21 867
|
24 538
|
32 568
|
36 438
|
40 205
|
61 231
|
80 289
|
69 035
|
|
| Other Current Liabilities |
9 061
|
11 523
|
13 645
|
18 055
|
16 998
|
26 484
|
35 164
|
26 348
|
23 743
|
24 477
|
|
| Total Current Liabilities |
52 961
|
68 540
|
77 191
|
82 418
|
103 993
|
141 915
|
153 159
|
147 947
|
162 238
|
186 041
|
|
| Long-Term Debt |
27 378
|
54 912
|
55 517
|
75 271
|
88 764
|
102 281
|
130 097
|
134 515
|
157 101
|
154 579
|
|
| Deferred Income Tax |
5 274
|
4 114
|
2 806
|
3 291
|
1 269
|
2 985
|
2 578
|
3 386
|
3 861
|
3 158
|
|
| Minority Interest |
0
|
6 521
|
3 855
|
4 173
|
5 890
|
8 253
|
10 751
|
11 071
|
12 683
|
12 863
|
|
| Other Liabilities |
803
|
1 363
|
4 836
|
4 197
|
2 837
|
5 540
|
7 180
|
6 463
|
6 166
|
6 328
|
|
| Total Liabilities |
86 416
N/A
|
135 451
+57%
|
144 205
+6%
|
169 350
+17%
|
202 754
+20%
|
260 974
+29%
|
303 763
+16%
|
303 381
0%
|
342 049
+13%
|
362 969
+6%
|
|
| Equity | |||||||||||
| Common Stock |
2 661
|
2 661
|
2 846
|
2 846
|
2 846
|
2 927
|
2 936
|
2 936
|
2 936
|
2 936
|
|
| Retained Earnings |
21 392
|
17 920
|
30 118
|
35 297
|
40 624
|
50 717
|
63 106
|
52 125
|
50 786
|
46 461
|
|
| Additional Paid In Capital |
7 548
|
7 613
|
14 696
|
14 700
|
19 883
|
19 915
|
19 993
|
20 071
|
20 123
|
20 135
|
|
| Unrealized Security Profit/Loss |
12 967
|
11 739
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
16
|
41
|
119
|
207
|
577
|
646
|
1 421
|
2 756
|
4 776
|
3 507
|
|
| Total Equity |
44 551
N/A
|
39 892
-10%
|
47 541
+19%
|
52 637
+11%
|
63 929
+21%
|
74 206
+16%
|
87 456
+18%
|
77 888
-11%
|
78 620
+1%
|
73 039
-7%
|
|
| Total Liabilities & Equity |
130 967
N/A
|
175 343
+34%
|
191 746
+9%
|
221 987
+16%
|
266 683
+20%
|
335 180
+26%
|
391 219
+17%
|
381 269
-3%
|
420 669
+10%
|
436 008
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 661
|
2 661
|
2 846
|
2 846
|
2 846
|
2 927
|
2 289
|
2 936
|
2 936
|
2 936
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
